Denuril 60mg Injection

Product Description

Denuril 60mg Injection contains the active ingredient Denosumab, which is used to treat osteoporosis, a condition characterized by weakened bones. It is also prescribed to help prevent bone complications in patients with certain types of cancer, such as multiple myeloma and bone metastases.

Denuril works by inhibiting a protein called RANK ligand, which is involved in the breakdown of bone tissue. By blocking this protein, Denuril helps increase bone density and reduce the risk of fractures, particularly in postmenopausal women with osteoporosis and in cancer patients with bone loss due to their condition. For patients with moderate renal impairment, close monitoring of kidney function may be necessary.

It is important to maintain adequate levels of calcium and vitamin D during treatment with Denuril. The medication should not be used in individuals with known hypersensitivity or allergic reactions to its components. Denuril is not approved for use in children and adolescents, as its safety and effectiveness in individuals under 18 years old have not been established. Additionally, caution is advised when using this medication in individuals with pre-existing hypoparathyroidism, a condition characterized by low parathyroid hormone levels.

Patients should consult their healthcare provider to ensure Denuril is the appropriate treatment for their condition.